Lower risk Drug recall · FDA · Published March 27, 2023

Preferred Pharmaceuticals recalls 0.25mg Alprazolam tabs due to cross-contamination risk

Preferred Pharmaceuticals recalls 30-count 0.25mg Alprazolam tabs (NDC 68788-7594-3, Lot G1822K) due to potential cross-contamination from another product during manufacturing.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0504-2023Drug Preferred Pharmaceuticals ›

Lower-risk recall

CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.

Take action

Contact the company

Recalling firmPreferred Pharmaceuticals, Inc.1250 N Lakeview Ave Ste O · Anaheim, CA 92807-1801

✎ GovInfoNow plain-language explainer

Preferred Pharmaceuticals is recalling 30-count 0.25mg Alprazolam tabs because of potential cross-contamination during manufacturing. This could affect people taking these medications if they are exposed to other drugs. Read more at govinfonow.com/recall/33751-preferred-pharmaceuticals-recalls-0-25mg-alprazolam-tabs-due-to-cross.

Source Summary by GovInfoNow · govinfonow.com/recall/33751-preferred-pharmaceuticals-recalls-0-25mg-alprazolam-tabs-due-to-cross · Updated August 17, 2026 · FDA enforcement record: FDA #D-0504-2023

Cite this page

“Preferred Pharmaceuticals recalls 0.25mg Alprazolam tabs due to cross-contamination risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33751-preferred-pharmaceuticals-recalls-0-25mg-alprazolam-tabs-due-to-cross. Based on FDA recall #D-0504-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0504-2023%22&limit=1).

The FDA announced on March 27, 2023, that Preferred Pharmaceuticals, Inc. voluntarily recalled Alprazolam Tab, USP 0.25mg due to potential cross-contamination from cGMP deviations. The agency classified the recall as Class II.

How to tell if you have it

Brand: Preferred Pharmaceuticals
Product: Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only
Manufacturer: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL
NDC: 68788-7594-3
Lot Code: G1822K
Expiration Date: 5/31/2023
Quantity: 30 Bottles
Distribution: Nationwide in the USA

The hazard

The recall addresses cGMP deviations resulting in a potential risk of cross-contamination. The product was manufactured by Breckenridge Pharmaceuticals, Inc.

Context

GovInfoNow's records show Preferred Pharmaceuticals, Inc. has 31 other recalls on record since August 15, 2018. Other recent recalls of similar products include Geri-Care Eye Drops Recalled for Sterility Risk (March 25, 2026), Preferred Pharma Recalls Ondansetron ODT Due to Defective Seals (November 17, 2025), and Preferred Pharma Recalls Clindamycin Capsules Due to cGMP Deviations (April 18, 2025). Other recent recalls of similar products include Golden State Medical Supply Primidone Tablets Recall: Cross Contamination Risk (April 27, 2026), Amerisource Health Primidone Tablets Recall: Cross Contamination Risk (May 1, 2026), and Glenmark Bisoprolol/Hydrochlorothiazide Tablets Recall: Cross Contamination Risk (November 21, 2025).

How to tell if you have this one

Check for the 30-count bottle labeled 'Alprazolam Tab, USP 0.25mg (CIV), Rx Only' with NDC 68788-7594-3 and Lot G1822K. The expiration date is May 31, 2023.

Brand
Preferred Pharmaceuticals
Category
Drug

FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Classification
Class II
Status
Terminated
Distribution
Nationwide in the USA

Recall number	Product, codes & lots	Quantity
D-0504-2023	Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. Ins:NDC 68788-7594-3; Lot: G1822K, Exp. Date:5/31/2023.	30 Bottles
D-0505-2023	Alprazolam Tab, USP 0.5mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7595-3), b) 60-count bottle (NDC 68788-7595-6), c) 90-count bottle (NDC 68788-7595-9); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL.; Lot # a) D2022P, Exp. Date:4/30/2023; F1022Y, E2022, I2822U, Exp. Date:6/30/2023; L2122W, Exp. Date: 8/31/2024; b) Lot #L0522A, Exp. Date:8/31/2024; B0823J, Exp. Date:11/31/2024; c) Lot# L1522P, Exp. Date: 10/31/2024.	320 x 30-count; 46 x 60-count; 10 x 90-count bottles
D-0506-2023	Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL.; Lot # a) H3122D, Exp. Date:8/31/2024; b) Lot #A1123R, L0522E, J2622H, I1622F, H2422E, Exp. Date:8/31/2024.	33 x 30-count; 78 x 60-count bottles

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for the NDC code 68788-7594-3 and lot number G1822K on the bottle label.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

Mar 27, 2023Firm started the recall
Apr 5, 2023FDA classified it Class II
Apr 12, 2023Published in FDA’s Enforcement Report
Oct 24, 2023FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

What should I do if I have the recalled product?

The recall does not require immediate action; check the product details and contact your healthcare provider if you have concerns.

Similar recalls

Other Preferred Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/33751-preferred-pharmaceuticals-recalls-0-25mg-alprazolam-tabs-due-to-cross">Preferred Pharmaceuticals recalls 0.25mg Alprazolam tabs due to cross-contamination risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0504-2023 (March 27, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0504-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.